PARSIPPANY, N.J. — GlaxoSmithKline Consumer Healthcare recently introduced Abreva Conceal, a clear nonmedicated patch that covers cold sores.
Abreva Conceal uses MicroAir technology, which allows air in while keeping contaminants out. Once the cold sore blister has appeared, Abreva Conceal can be placed over it, creating a covered, protected environment for up to eight hours and provides a smooth surface so that makeup can be applied on top of the patch. GSK said the product delivers true product innovation and will drive significant growth in the cold sore category.
